October 10, 2018 New Frontiers in Parkinson’s Disease: From Genetics to the Clinic Shihabuddin LS, Brundin P, Greenamyre JT, Stephenson D, Sardi SP. New Frontiers in Parkinson’s Disease: From Genetics to the
September 25, 2018 Best Practices for Avoiding Paper Backup When Implementing Electronic Approaches to Patient-Reported Outcome Data Collection in Clinical Trials Howry, C, E CA, Crescioni, M, E S,, O’Donohoe, P, R T,. Best Practices for Avoiding Paper Backup When Implementing Electronic Ap
September 25, 2018 UA Colleges of Law and Pharmacy, Critical Path Institute, Launch Graduate Certificate Program in Regulatory Science Designed for graduate students and working professionals, the certificate program provides specialized training in navigating the
September 17, 2018 Critical Path Institute and SIGNATOPE GmbH Team Up to Advance Research on Biomarkers for Drug-induced Organ Injuries TUCSON, Ariz. and REUTLINGEN, September 17, 2018 — Critical Path Institute’s Predictive Safety Testing Consortiu
September 6, 2018 Doris Duke Charitable Foundation Awards Grant to Critical Path Institute to Advance Therapies for Sickle Cell Disease Contacts: Kissy Black, Critical Path Institute kissyblack@lotosnile.com, 615.298.1144 Kristin Roth-Schrefer, Communications Direct
August 10, 2018 CPAD Has Two Posters Accepted to Alzheimer’s Association International Conference The Alzheimer’s Association International Conference (AAIC) is the largest annual scientific meeting with focus on Alzheimer dis
August 10, 2018 Evidence-Based Treatment Decisions In Transplantation: The Right Dose & Regimen for the Right Patient/Individualized Treatment The following originally appeared on fda.gov: Summary: The Food and Drug Administration is announcing the following public worksho
August 3, 2018 Quantitative Approach for Cardiac Risk Assessment and Interpretation in Tuberculosis Drug Development
July 30, 2018 Perceived Burden of Completion of Patient-Reported Outcome Measures in Clinical Trials: Results of a Preliminary Study Bodart, S B B, Crescioni, M E S,, Flood, E and on behalf of the ePRO C. Perceived Burden of Completion of Patient-Reported Outcome
July 26, 2018 First-ever biomarker qualified for Parkinson’s is a vital step toward improved clinical trials FOR IMMEDIATE RELEASE Contact: Kissy Black 615.298.1144 kissyblack@lotosnile.com Tucson, AZ — July 26, 2018 – The Criti
